Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial

<strong>Background<br></strong> Aspirin is widely used for cardioprotection with its antiplatelet effects due to the blocking of thromboxane A2 production. However, it has been suggested that platelet abnormalities in those with diabetes prevent adequate suppression with once daily...

Podrobná bibliografie
Hlavní autoři:	Parish, S, Buck, G, Aung, T, Mafham, M, Clark, S, Hill, M, Collins, R, Bowman, L, Armitage, J
Další autoři:	ASCEND Study Collaborative Group
Médium:	Journal article
Jazyk:	English
Vydáno:	BioMed Central 2023

Podobné jednotky

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
Autor: Sarah Parish, a další
Vydáno: (2023-03-01)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
Autor: Aung, T, a další
Vydáno: (2017)

Thromboxane biosynthesis and future events in diabetes: the ASCEND trial
Autor: Petrucci, G, a další
Vydáno: (2024)

Influence of smoking and smoking cessation on levels of urinary 11-dehydro thromboxane B2
Autor: Angela van der Plas, a další
Vydáno: (2018-01-01)

Urinary leukotriene E4 and 11-dehydro-thromboxane B2 excretion in children with bronchial asthma
Autor: Kaori Yoshikawa, a další
Vydáno: (2004-01-01)

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
Autor: Rocca, B, a další
Vydáno: (2020)

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
Autor: Parish, S, a další
Vydáno: (2022)

Urinary 11‐Dehydro‐Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study
Autor: Wojciech Szczeklik, a další
Vydáno: (2016-08-01)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
Autor: Sammons, E, a další
Vydáno: (2024)

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
Autor: Bowman, L, a další
Vydáno: (2017)

ASCEND-eye: rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
Autor: Sammons, E, a další
Vydáno: (2023)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Autor: Sammons, EL, a další
Vydáno: (2024)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Autor: Sammons, EL, a další
Vydáno: (2024)

ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomised trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
Autor: Emily Sammons, a další
Vydáno: (2023-10-01)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Autor: Emily L. Sammons, a další
Vydáno: (2024-11-01)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
Autor: Mafham, MM, a další
Vydáno: (2019)

ASCEND-Eye: effects of omega-3 fatty acids on diabetic retinopathy
Autor: Sammons, E, a další
Vydáno: (2023)

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
Autor: Clarke, R, a další
Vydáno: (1991)

Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs
Autor: John M. Thomason, a další
Vydáno: (2019-11-01)

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation
Autor: Giovanna Petrucci, a další
Vydáno: (2022-12-01)

Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT.
Autor: Thomas J Montine, a další
Vydáno: (2010-02-01)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
Autor: Harper, C, a další
Vydáno: (2021)

Total synthesis of dehydro-boscialin glucoside
Autor: Karsten Krohn, a další
Vydáno: (2006-09-01)

Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays
Autor: Giovanna Petrucci, a další
Vydáno: (2024-03-01)

Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples
Autor: Giovanna Petrucci, a další
Vydáno: (2024-11-01)

Aspirin affects early phases of metastasis through the inhibition of COX-1-thromboxane A2 axis
Autor: Lucotti, S
Vydáno: (2016)

Effects of aspirin for primary prevention in persons with diabetes mellitus
Autor: Bowman, L, a další
Vydáno: (2018)

Aspirin resistance status as determined by urinary thromboxane B2 (TXB2) level in patients with ischemic heart disease and its relationship with Severity of coronary artery disease
Autor: Naghmeh Ziaie, a další
Vydáno: (2011-01-01)

Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2
Autor: Lucotti, S, a další
Vydáno: (2019)

Sustainable Triazine-Based Dehydro-Condensation Agents for Amide Synthesis
Autor: Roberto Sole, a další
Vydáno: (2021-01-01)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
Autor: Harper, C, a další
Vydáno: (2021)

Aspirin for primary prevention of vascular disease in people with diabetes.
Autor: Haynes, R, a další
Vydáno: (2009)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
Autor: Guillaume Marquis‐Gravel, a další
Vydáno: (2024-02-01)

Thromboxane Modulates Endothelial Permeability
Autor: J. M. Klausner, a další
Vydáno: (1994-01-01)

Stability of thromboxane in blood samples
Autor: Helgadóttir H, a další
Vydáno: (2019-06-01)

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
Autor: Aung, T, a další
Vydáno: (2016)

Effects of omega−3 fatty acid supplements on arrhythmias
Autor: Parish, S, a další
Vydáno: (2020)

Weight loss in a cardiovascular trial population identifies people at future risk of dementia
Autor: van der Veere, P, a další
Vydáno: (2022)

Cellular and Structural Basis of Synthesis of the Unique Intermediate Dehydro-F420-0 in Mycobacteria
Autor: Rhys Grinter, a další
Vydáno: (2020-06-01)

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes
Autor: Praveen Patel, a další
Vydáno: (2025-02-01)